{
  "ticker": "JNJ",
  "target_date": "2025-09-22",
  "actual_date": "2025-09-22",
  "collected_at": "2025-12-08T12:18:31.797431",
  "price": {
    "open": 174.98,
    "high": 175.53,
    "low": 173.02,
    "close": 173.1108856201172,
    "volume": 7193900,
    "change_1d_pct": -1.12,
    "change_7d_pct": -2.4,
    "change_30d_pct": 1.25
  },
  "technicals": {
    "rsi_14": 38.21,
    "sma_20": 175.85,
    "sma_50": 170.9,
    "macd": 0.952,
    "macd_signal": 1.773,
    "macd_histogram": -0.822,
    "bb_upper": 178.47,
    "bb_lower": 173.23,
    "price_vs_sma20_pct": -1.56,
    "price_vs_sma50_pct": 1.29,
    "volume_ratio": 0.88
  },
  "fundamentals": {
    "market_cap": 487352205312,
    "pe_ratio": 19.525097,
    "forward_pe": 19.083017,
    "price_to_book": 6.139558,
    "price_to_sales": 5.288741,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.66,
    "pct_from_52w_low": 43.79
  },
  "macro": {
    "spy": {
      "price": 666.84,
      "change_1d_pct": 0.47,
      "change_7d_pct": 1.72
    },
    "vix": {
      "level": 16.1,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.14
    },
    "dollar_index": {
      "level": 97.33
    },
    "gold": {
      "price": 3740.7
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Kenvue Stock Hits All-Time Low, Turns Higher After-Hours",
      "source": "Yahoo",
      "datetime": 1758579504,
      "summary": "Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground afterhours as President Trump warned that acetaminophen, the active ingredient in Kenvue's Tylenol, is a potential cause of autism.  Kenvue shares were down 7.5% Monday, putting ",
      "url": "https://finnhub.io/api/news?id=7ee8659d9e091c5a16f9e09a129b5e9e889b7f1935c315cd3a71e9adce9344a8"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Announced the European launch of Its Shockwave Javelin Peripheral IVL Catheter",
      "source": "Yahoo",
      "datetime": 1758575734,
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 15 Best Stocks to Invest in for Financial Stability. On September 15, 2025, Johnson & Johnson (NYSE:JNJ) announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, which is a groundbreaking platform to treat peripheral artery disease (P",
      "url": "https://finnhub.io/api/news?id=3b65cc6c6819867fb017fa8226c5d7d6bafc2b37dcac233446f431f21f6345df"
    },
    {
      "headline": "Tylenol-maker Kenvue\u2019s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials",
      "source": "Yahoo",
      "datetime": 1758567535,
      "summary": "Kenvue rebuked claims of a connection between autism and acetaminophen and said it is \u201cdeeply concerned with the health risk this poses for expecting mothers.\u201d",
      "url": "https://finnhub.io/api/news?id=d846c66a2f73bd56ca958df7e20499a4c6761bc9cf0c988e0c21d0b110b7699a"
    },
    {
      "headline": "What is Kenvue? The Tylenol maker facing RFK Jr. scrutiny over autism claims",
      "source": "Yahoo",
      "datetime": 1758564313,
      "summary": "Kenvue just opened its global headquarters in New Jersey. Here's what to know about the company and its CEO.",
      "url": "https://finnhub.io/api/news?id=04fb0c808c5a2135e878b990fc3c9ba73f648c7423944da0c9b429a5fa13c228"
    },
    {
      "headline": "J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?",
      "source": "Yahoo",
      "datetime": 1758546960,
      "summary": "J&J shares gain 17.7% in three months, adding $63B to its market cap. Technical and pipeline momentum fuel investor interest.",
      "url": "https://finnhub.io/api/news?id=301fa5dee2bfb68927c72f4c6d99eeb220ebda6e42792338336bc1c45477fe9b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}